Risultati di ricerca
ICON is a global CRO, with a presence in Japan since 1996. We provide full geographic reach, to allow for the most efficient site monitoring. With over 950 staff in Tokyo, Osaka, and home-based, we deliver global and local capabilities to pharmaceutical, biotechnology, medical device and government and public health organisations.
21 feb 2024 · ICON regularly contributes thought leadership to industry media publications and conferences, and has been recognised as one of the world’s leading Contract Research Organisations through a number of high-profile industry awards.
ICON offers a broad range of specialised services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. Our services span the entire lifecycle of product development and can be adapted to suit small local trials or large global programs.
17 gen 2024 · ICON plc | 515,496 followers on LinkedIn. Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save ...
1. ICON has the world's largest dedicated biotech division. 8,000+. staff dedicated exclusively to biotech customers. 500+. ICON supports over 500 biotech sponsors annually. Our empowered structure enables flexibility and quick decision-making within the global reach one of the world’s biggest and most innovative CROs.
We use different systems to manage applications at ICON. Once you apply, ICON will send you a confirmation email, including your login information, which you can use to manage your application. If you received communication about your application from WorkdayNoReply - icon@myworkday.com. Please click here to manage your Full Service application.
About ICON Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We are a global provider of consulting, and outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government and public health organisations.
